Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spectranetics
Colorado Springs, Colorado, United Statesspectranetics.com ↗
- Ownership
- Private
- Employees
- ~900
- Development stage
- Other
01
Overview
Spectranetics developed and commercialized a portfolio of medical devices for vascular intervention—including laser atherectomy catheters for treating coronary and peripheral artery disease as well as the Stellarex drug-coated balloon. The company’s products were supported by robust clinical evidence and had obtained regulatory approvals in the US (FDA PMA) and Europe (CE mark). At the time of acquisition by Philips in 2017, sales were growing at double-digit rates with projected 2017 revenue around $300 million[1][5].
- Therapeutic areas
- Cardiovascular
- Modalities
- Device
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on Spectranetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Spectranetics.